NYU Medical Center has entered into a strategic alliance with Siemens Medical Solutions. The cornerstone of the alliance is a seven-year agreement that makes Siemens the exclusive supplier of the center's radiology imaging. The commercial value of the
NYU Medical Center has entered into a strategic alliance with Siemens Medical Solutions. The cornerstone of the alliance is a seven-year agreement that makes Siemens the exclusive supplier of the center's radiology imaging. The commercial value of the agreement will exceed $110 million, according to the company. The agreement covers approximately 100 advanced imaging systems, including a high-resolution research 7T MR scanner. Also included will be CTs, PET scanners, mammography, digital x-ray, and ultrasound equipment, as well as PACS. Due to the size and scope of the agreement, NYU and Siemens expect it will take four years to install all of the equipment and systems.
Another key aspect of the alliance is the commitment from both partners to MR imaging research. NYU plans to construct a new MR research facility near its midtown campus in Manhattan to house some of the new equipment, including the new 7T system, which will require a special room reinforced by some 300 tons of steel. Siemens will also install two 3T scanners dedicated to imaging research, particularly of the human brain, liver, kidneys, and prostate.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.